BOBABAM’s donation will help Project Potluck provide opportunities to the next generation of BIPOC entrepreneurs and young professionals in their future endeavors.
Monster will acquire Bang Energy’s performance beverages and related Bang Energy businesses
July 5, 2023
Under the terms of the APA, subject to satisfaction of certain closing conditions, Monster will acquire Bang Energy’s performance beverages and related Bang Energy businesses through the purchase of substantially all of Bang Energy’s assets.
Want to listen to industry news and views on the way to work? Catch a quick video on a lunchbreak? Prepared Foods now goes anywhere—and everywhere—to cover critical topics.
Farbest Brands has hired Joe Rios as Technical Sales Manager, the latest in a slew of strategic organizational changes to support investment in new product lines and ingredients, specifically in hydrocolloids.
Expansion in North America includes the addition of Aroma Ingredients from Camlin Fine Sciences, Ltd.
June 29, 2023
From specialty ingredient innovation to recipe testing, food brands of all sizes turn to Foodology by Univar Solutions for help with tackling product development challenges.
Company attracts top food and beverage executives from Danone, Pepsico and Nestle
June 23, 2023
Remilk's new board appointees are renowned C-suite level industry leaders with track records of transformation, innovation, and breakthrough achievements.
The food ingredients joint venture builds upon the existing long-term strategic partnership between the two companies
June 23, 2023
The agreement combines the technology, product portfolio and backward integration of the Celanese Food Ingredients business with Mitsui’s long-standing positions across the food value chain in Asia and other regions.
Company begins production and prepares for launch with restaurateur José Andrés
June 23, 2023
The moment for the burgeoning cultivated meat, poultry and seafood sector, and for the global food industry, comes on the heels of the USDA’s approval of GOOD Meat’s label – and four months after the company received its “no questions” letter from the US Food and Drug Administration.
The company intends to use the net proceeds of the initial public offering for repayment of indebtedness, working capital and general corporate purposes
June 22, 2023
The gross proceeds from the offering, before underwriting discounts and commissions and estimated offering expenses payable by the company, are $7,140,000.